Spanish Red Biotech Pipeline

ADmit Therapeutics

ADmit Test

Type: Biomarkers / Diagnostic
Therapeutic area: Central Nervous System
Indication: Alzheimer's disease in prodromic stage (Mild Cognitive Impairment)
Phase: 3Clinical validation, 2Preclinical Validation, 1R+D
Studies location: Spain, Australia